Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
| NAV2024-04-25 | Chg.-22.5300 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 1,926.8199EUR | -1.16% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | -23.24 | -4.43 | 3.75 | 3.78 | 5.33 | -8.43 | 12.46 | -2.53 | 3.75 | -12.49 | 8.75 | -2.94 | -19.97% |
| 2017 | 5.35 | 6.80 | -0.20 | 1.09 | -3.22 | 9.15 | 2.42 | 6.37 | 0.68 | -6.52 | 0.12 | 1.45 | +24.87% |
| 2018 | 6.60 | -4.86 | -2.17 | -3.34 | 4.39 | 0.63 | 4.29 | 3.92 | -2.21 | -14.22 | 3.85 | -8.55 | -13.02% |
| 2019 | 12.85 | 3.33 | -0.81 | -5.08 | -4.94 | 9.21 | -2.52 | -2.51 | -4.38 | 10.29 | 11.72 | 2.21 | +30.43% |
| 2020 | -5.35 | -1.19 | -5.42 | 12.40 | 9.51 | 1.27 | -2.96 | 0.83 | 0.64 | -2.75 | 9.44 | 2.92 | +18.93% |
| 2021 | 1.81 | -2.57 | -4.35 | 2.71 | -2.27 | 6.35 | -1.45 | 3.89 | -4.27 | 0.17 | -4.38 | 2.32 | -2.71% |
| 2022 | -10.88 | -1.96 | 5.39 | -7.76 | -3.50 | 2.63 | 4.48 | 0.83 | -2.35 | 6.56 | 5.77 | -3.11 | -5.50% |
| 2023 | 2.75 | -5.94 | 0.32 | 2.02 | -1.38 | 1.02 | -0.32 | -0.34 | -4.46 | -6.26 | 5.71 | 13.23 | +4.95% |
| 2024 | 1.22 | 1.20 | -0.07 | -7.47 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 15.90% | 18.51% | 16.10% | 20.07% | 22.72% |
| Sharpe ratio | -1.25 | 1.17 | -0.24 | -0.32 | 0.06 |
| Best month | +13.23% | +13.23% | +13.23% | +13.23% | +13.23% |
| Worst month | -7.47% | -7.47% | -7.47% | -10.88% | -10.88% |
| Maximum loss | -11.21% | -11.21% | -15.74% | -30.29% | -32.04% |
| Outperformance | +1.76% | - | +1.73% | -5.87% | +3.46% |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,921.4600 | +2.25% | -0.61% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 208.1400 | +4.41% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 1,926.8199 | -0.03% | -7.54% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,092.0100 | +4.68% | +11.74% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,227.6599 | +1.41% | +9.02% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 339.6200 | +2.10% | +12.77% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 306.8900 | +5.38% | +14.35% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 188.5900 | -1.74% | -8.61% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,723.8101 | +3.10% | +2.15% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 140.0100 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 561.0800 | +1.57% | -2.32% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,257.0898 | +2.13% | -0.98% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 184.9100 | -0.21% | -7.67% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 192.7000 | +0.65% | -5.40% | |
| Candriam Equities L Biotech.R US... | reinvestment | 249.9000 | +2.84% | +1.38% | |
| Candriam Equities L Biotech.C US... | reinvestment | 787.3900 | +1.95% | -1.07% | |
| Candriam Equities L Biotech.C US... | paying dividend | 723.3100 | +1.92% | -1.17% |
Performance
| YTD | -5.27% | ||
|---|---|---|---|
| 6 Months | +12.01% | ||
| 1 Year | -0.03% | ||
| 3 Years | -7.54% | ||
| 5 Years | +28.54% | ||
| Since start | +28.45% | ||
| Year | |||
| 2023 | +4.95% | ||
| 2022 | -5.50% | ||
| 2021 | -2.71% | ||
| 2020 | +18.93% | ||
| 2019 | +30.43% | ||
| 2018 | -13.02% | ||
| 2017 | +24.87% | ||
| 2016 | -19.97% | ||
